Credit Suisse Ag Molecular Templates, Inc. Transaction History

Credit Suisse Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.33 - $12.0 $338,250 - $12.3 Million	1,025,000 New	1,025,000 $338,000
Q2 2022 Aug 12, 2022	BUY	$0.81 - $3.43 $16 - $68	20 New	20 $0
Q4 2021 Feb 14, 2022	SELL	$3.37 - $6.87 $73,078 - $148,975	-21,685 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.78 - $7.86 $5,080 - $6,908	879 Added 4.22%	21,685 $145,000
Q2 2021 Aug 16, 2021	BUY	$7.82 - $12.44 $36,918 - $58,729	4,721 Added 29.35%	20,806 $163,000
Q1 2021 May 14, 2021	BUY	$9.33 - $14.05 $35,034 - $52,757	3,755 Added 30.45%	16,085 $203,000
Q4 2020 Feb 12, 2021	BUY	$8.48 - $12.23 $104,558 - $150,795	12,330 New	12,330 $116,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.